New to Meducation?
Sign up
Already signed up?
Log In
Add To Boards
Add
Upvote
1
CPD Tracker
00:00
SABCS Spin-Off | 06 - Burstein
Most patients with ER-positive, HER2-negative, node-negative breast cancer should be presented with the option of participating in the TAILORx trial and of having the Oncotype DX assay performed outside of a trial.
#Dermatology
x
#Oncology
x
#Dentistry
x
#MedicalOncology
x
#BreastNeoplasms
x
Help by adding tags...
Write a Comment
Sign in and join the discussion
BCU 3 | 06 - Tumor Panel
- Miami Breast Cancer Conference Tumor Panel Discussion on Adjuvant Systemic Therapy
1
11
Trending
Blood groups and Haemolytic Disease of the Newborn
- A poster detailing Rhesus and ABO blood systems, and a brief outline of Haemolytic Disease of the Newborn.
117
2215
BCUS ASBS 2008 | Roundtable discussion
- Breast Cancer Update for Surgeons – Proceedings and Interviews from a CME Symposium at the 9th Annual Meeting of The American Society of Breast Surgeons
1
9
MTPB4 2007 | Case 04 Patterns of Care Discussion
- MeetTheProfessors.com – Patterns of Care Case Discussion; postmenopausal woman with progressive Stage IV, ER-positive, HER2-negative breast cancer presented to Drs Winer and Carey
1
13
MTPB4 2007 | Case 05 presented by Brenda L Towell, MD
- MeetTheProfessors.com – Case from the practice of Brenda L Towell, MD; 55-year-old who presented at 46 with a 1.7-cm, ER-pos, PR-pos breast tumor and 22 neg lymph nodes presented to Drs Winer and C...
1
8
Write a Comment
Sign in and join the discussion